Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Colulintide by Eli Lilly and Co for Obesity: Likelihood of Approval
Colulintide is under clinical development by Eli Lilly and Co and currently in Phase I for Obesity. According to GlobalData,...